Wirkweise

Thigpen AE et al. (1993). Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. The Journal of clinical investigation, 92(2), pp. 903-910.

Griffin, J., und Wilson, J. (2003). Disorders of the testes and the male reproductive tract. In P. Larsen, H. Kronenberg, S. Melmed, & K. Polonsky (Eds.), Williams textbook of endocrinology (10 ed., pp. 709–69). Philadelphia: WB Saunders.

Gooren, L., & Bunck, M. (2004). Androgen replacement therapy: present and future. Drugs , 64 (17), pp. 1861-91.

Marks LS, Mazer NA, Mostaghel E., et al. (2006). Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. Jama, 296(19), pp. 2351-2361.

Wang C, Berman N, Longstreth JA, et al. (2000). Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study. J Clin Endocrinol Metab, 85(3),pp. 964-969.

Swerdloff RS, Wang C., Cunningham G., et al. (2000). Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab, 85(12), pp. 4500-4510.